Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Split Arm Study to Evaluate the Safety Following Injection of GP0045 Compared to Restylane Lyft Lidocaine

NCT03133325 is registered in ClinicalTrials.gov with Galderma R&D as lead sponsor.

NCT NCT03133325
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03133325 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Split Arm Study to Evaluate the Safety Following Injection of GP0045 Compared to Restylane Lyft Lidocaine
Lead sponsor
Galderma R&D
Phase
Not applicable
Overall status
Completed
Start date
April 19, 2017
Completion date
July 13, 2017
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

safety